Selinexor in multiple myeloma
EA Martino, E Vigna, A Bruzzese… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Selinexor, an XPO1 inhibitor, has emerged as a promising therapeutic option in
the challenging landscape of relapsed/refractory multiple myeloma (RRMM). Areas covered …
the challenging landscape of relapsed/refractory multiple myeloma (RRMM). Areas covered …
[PDF][PDF] Selinexor in multiple myeloma
FM Labanca, E Lucia, V Olivito, A Zimbo - 2024 - researchgate.net
Introduction: Selinexor, an XPO1 inhibitor, has emerged as a promising therapeutic option in
the challenging landscape of relapsed/refractory multiple myeloma (RRMM). Areas covered …
the challenging landscape of relapsed/refractory multiple myeloma (RRMM). Areas covered …